Please refer to attachment.

Regulatory & Legal View source PDF Explain this filing

INDIAGLYCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹991.40

prior close

₹1008.20

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.1%-0.7% vs market

Breweries & Distilleries peers, median of 25sector-0.2%-0.4% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.4 pts less than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.8

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.1-0.7-0.2-0.4

Next day

+1.5+1.7-0.2+1.1+0.4

+1.7+2.4-0.7+1.2+0.5

+1.1+2.4-1.3+0.7+0.4

-1.2+1.7-2.9-0.1-1.1

+0.2+0.6-0.4-2.0+2.2

-0.6+1.9-2.6-2.0+1.4

15d

-1.6+4.9-6.4-0.4-1.2

-3.7+8.9-12.6+0.7-4.4

+15.0+7.5+7.5-2.5+17.5

+20.4+13.6+6.8-6.6+27.0

UpDownMarket · Nifty Microcap 250Sector · Breweries & Distilleries peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India Glycols Limited filed an update regarding the ongoing NCLT proceedings for its proposed scheme of arrangement involving the demerger into two resulting companies — Ennature Biopharma Limited and IGL Spirits Limited. The matter was listed for hearing on 21st May 2026 but could not be taken up due to time constraints. The next hearing date is yet to be notified by the NCLT Allahabad Bench at Prayagraj. This is a routine procedural update and does not indicate any new development in the demerger process.

Likely market impact

The deferral of the hearing has no immediate impact on shareholders. The demerger scheme remains pending for NCLT approval, and investors should await further updates on the next hearing date.